FDA Mulls Which EU Inspections To Skip Under EU MRA

As US FDA sets its FY 2018 inspection priorities, it is considering whether there are recent or upcoming inspections by inspectorates in eight European countries recognized under a US/EU mutual recognition agreement that it could rely on instead, agency official says. Over time, FDA could rely more on EU inspection priorities.

US-EU-Flags_169048001_1200.jpg

More from Compliance

More from Pink Sheet